For years, we’ve fought to grow federal funding for kidney cancer research, reaching $50 million annually for the Kidney Cancer Research Program (KCRP) within the Congressionally Directed Medical Research Programs (CDMRP). But with the passage of the March 2025 Continuing Resolution (CR), CDMRP funding has been slashed by 57%—a devastating setback for patients, researchers, and the future of kidney cancer treatment.
KidneyCAN is actively working to protect this funding. We are in direct communication with leaders at CDMRP and key decision-makers, strategizing ways to minimize the impact of these cuts and restore funding for kidney cancer research.
Our message remains clear: medical research is not political. Cancer affects Republicans and Democrats alike, and funding research is a bipartisan priority that saves lives. We will continue to fight for every dollar needed to advance kidney cancer research and accelerate cures.
We are launching a focused advocacy initiative to protect KCRP funding and mobilize grassroots action. Stay tuned for details on how you can get involved.